Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Active, not recruiting Observational

Reorganization Strategy to Optimize the Use of Virtual Reality

NCT07132710 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-03-01
Last updated
2025-08-20

Condition(s) studied

Adult Patients Managed in a Cardiac Critical Care Unit With a Pathology Requiring at Least One Potentially Painful and Anxiety-provoking Invasive Procedure

Investigational drug(s) / intervention(s)

Semi-structured interviews

Semi-structured interviews: Patients and caregivers will be interviewed about the barriers and facilitators to the use of VR masks in the management of pain and anxiety, in order to propose organizational changes that encourage their use.

Study summary

The benefits of virtual reality (VR) in managing pain and anxiety for critical care patients has never been demonstrated, even if a positive effect has been demonstrated in other populations of patients. A preliminary survey in 8 critical care units equipped with the VR mask, identified a under-use of masks by critical care teams. Before addressing the question of the effectiveness of the VR mask in a population of critical care patients, we must first identify the barriers and facilitators to its use and propose a new organization in critical care units promoting the use of VR mask by autonomous caregivers. A qualitative study will be conducted with patients and caregivers of a critical care unit to identify the barriers and facilitators to the use of virtual reality masks in the management of pain and anxiety by caregivers.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Volunteer caregivers working in the cardiac critical care unit for at least 6 months. * Adult patients treated in the unit with a condition requiring at least one potentially painful and anxiety-provoking invasive procedure (e.g., Central Venous Line placement, Arterial Catheter Insertion, ...) allowing the use of the VR mask. * Patients able to understand the instructions without language barriers, to ensure the validity of the interviews and the quality of the data collected. Exclusion Criteria: * Staff not volunteering to participate in the study. * Patients whose condition presents a medical contraindication to the use of VR mask or who present cognitive disorders.

Primary outcome measure(s)

  • Identify the barriers and facilitators to the use of virtual reality mask by paramedical staff in the management of invasive care for critical care patients — Participants will be interviewed once (about one-hour interview)
    Patients and caregivers of a cardiac critical care unit will be interviewed (semi-structured interviews) to gather their perceptions on the use of virtual reality mask for pain and anxiety management in invasive care for critical care patients

Trial sites (1)

FacilityCityRegionStatus
Hôpital Louis Pradel - Hospices Civils de Lyon Bron France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07132710 on ClinicalTrials.gov ↗ ← All trials in France